Tuberculosis of the central nervous system: Recognition, diagnosis and treatment in a low-prevalence country

Acute Medicine

Volumn 7, Issue 3, 2008, Pages 113-121

  Pollock, Katrina M ^a   Lalvani, Ajit ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Central nervous system; Tuberculoma; Tuberculosis; Tuberculous meningitis

Indexed keywords

DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PREDNISOLONE; PROTIONAMIDE; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN;

BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; HUMAN; LIVER TOXICITY; LYMPH NODE BIOPSY; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; PERIPHERAL NEUROPATHY; PREVALENCE; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; TUBERCULOMA; TUBERCULOUS MENINGITIS; UNITED KINGDOM;

EID: 67749137286     PISSN: 17474884     EISSN: 17474892     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. WHO. Global tuberculosis control-surveillance, planning, financing. 2008; Available from: http://www.who.int/tb/publications/global_report/ 2008/en/
2. Thwaites GE, Chau TT, Stepniewska K, et al; Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360: 1287-92.
3. HPA. Available from: http://www.hpa.org.uk/webw/ HPAweb&HPAwebStandard/HPAweb_C/1225354113418?p=1204186170287.
4. Rose AM, Watson JM, Graham C, et al; Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 2001; 56: 173-9.
5. Martineau AR, Lowey H, Tocque K, et al; Decreasing tuberculosis case fatality in England and Wales, 1988-2001. Int J Tuberc Lung Dis 2004; 8: 737-42.
6. Dinnes J, Deeks J, Kunst H, et al; A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007; 11: 1-196.
7. NICE. Clinical diagnosis and managment of tuberculosis and measures for its prevention and control. NICE; Available from: http://www.nice.org.uk:80/nicemedia/pdf/CG033FullGuideline.pdf.
8. Ormerod P: Non-respiratory tuberculosis, Davies PDO, Barnes PF, Gordon SB, editors: Clinical Tuberculosis. London, 2008, Hodder Arnold; Chapter. 10, p. 163.
9. Pagnoux C, Genereau T, Lafitte F, et al; Brain tuberculomas. Ann Med Interne (Paris) 2000; 151: 448-55.
10. Schwander SK, Ellner JJ: Human immune response to M. tuberculosis, Davies PDO, Barnes PF, Gordon SB, editors: Clinical Tuberculosis, 2008, Hodder Arnold; Chapter 8, p. 121.
11. Lucas SB: Histopathology, Davies PDO, Barnes PF, et al, editors: Clinical Tuberculosis. London, 2008, Hodder Arnold; Chapter 7, p. 105.
12. Tufariello JM, Chan J, Flynn JL; Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003; 3: 578-90.
13. Horsburgh CR, Jr.; Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-7.
14. Sharma SK, Mohan A, Sharma A, et al; Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005; 5: 415-30.
15. Vidal JE, Hernandez AV, Oliveira AC, et al; Cerebral tuberculomas in AIDS patients: a forgotten diagnosis? Arq Neuropsiquiatr 2004; 62: 793-6.
16. Unal A, Sutlas PN; Clinical and radiological features of symptomatic central nervous system tuberculomas. Eur J Neurol 2005; 12: 797-804.
17. Kim TK, Chang KH, Kim CJ, et al; Intracranial tuberculoma: comparison of MR with pathologic findings. AJNR Am J Neuroradiol 1995; 16: 1903-8.
18. Brandli O; The clinical presentation of tuberculosis. Respiration 1998; 65: 97-105.
19. Thwaites GE, Duc Bang N, Huy Dung N, et al; The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis 2005; 192: 2134-41.
20. Lu CH, Chang WN, Chang HW; The prognostic factors of adult tuberculous meningitis. Infection 2001; 29: 299-304.
21. Schutte CM; Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 2001; 29:213-7.
22. Koh SB, Kim BJ, Park MH, et al; Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. J Clin Neurosci 2007; 14: 1073-7.
23. Kinirons P, Baily C, De Gascun C, et al; Lymphocytic meningitis: incidence, causes and outcomes over five years. Ir Med J 2005; 98:238-40.
24. Tunkel AR, Glaser CA, Bloch KC, et al; The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303-27.
25. Bicanic T, Harrison TS; Cryptococcal meningitis. Br Med Bull 2004; 72: 99-118.
26. Oncul O, Baylan O, Mutlu H, et al; Tuberculous meningitis with multiple intracranial tuberculomas mimicking neurocysticercosis clinical and radiological findings. Jpn J Infect Dis 2005; 58: 387-9.
27. Hoitsma E, Faber CG, Drent M, et al; Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004; 3: 397-407.
28. Pai M, Riley LW, Colford JM, Jr.; Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-76.
29. Karstaedt AS, Valtchanova S, Barriere R, et al; Tuberculous meningitis in South African urban adults. QJM 1998; 91: 743-7.
30. Wasay M, Kheleani BA, Moolani MK, et al; Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging 2003; 13: 240-7.
31. Thomas MM, Hinks TS, Raghuraman S, et al; Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int J Tuberc Lung Dis 2008; 12: 651-7.
32. Quan C, Lu CZ, Qiao J, et al; Comparative evaluation of early diagnosis of tuberculous meningitis by different assays. J Clin Microbiol 2006; 44: 3160-6.
33. Bouchama A, al-Kawi MZ, Kanaan I, et al; Brain biopsy in tuberculoma: the risks and benefits. Neurosurgery 1991; 28: 405-9.
34. Field M, Witham TF, Flickinger JC, et al; Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 2001; 94: 545-51.
35. McGirt MJ, Woodworth GF, Coon AL, et al; Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005; 102: 897-901.
36. Dammers R, Haitsma IK, Schouten JW, et al; Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 2008; 150: 23-9.
37. Woodworth GF, McGirt MJ, Samdani A, et al; Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 2006; 104: 233-7.
38. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998; 53: 536-48.
39. Ormerod LP, Skinner C, Wales J; Hepatotoxicity of antituberculosis drugs. Thorax 1996; 51: 111-3.
40. Breen RA, Miller RF, Gorsuch T, et al; Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax 2006; 61: 791-4.
41. Ungo JR, Jones D, Ashkin D, et al; Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 1998; 157: 1871-6.
42. Thwaites GE, Nguyen DB, Nguyen HD, et al; Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-51.
43. Hachad H, Ragueneau-Majlessi I, Levy RH; New antiepileptic drugs: review on drug interactions. Ther Drug Monit 2002; 24: 91-103.
44. Thwaites GE, Simmons CP, Than Ha Quyen N, et al; Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis. J Infect Dis 2003; 188: 1105-15.
45. AbdulJabbar M; Paradoxical response to chemotherapy for intracranial tuberculoma: two case reports from Saudi Arabia. J Trop Med Hyg 1991; 94: 374-6.
46. Reiser M, Fatkenheuer G, Diehl V; Paradoxical expansion of intracranial tuberculomas during chemotherapy. J Infect 1997; 35: 88-90.
47. Dautremer J, Pacanowski J, Girard PM, et al; A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis. AIDS 2007; 21: 381-2.
48. Lee CH, Lui CC, Liu JW; Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma. AIDS Patient Care STDS 2007; 21: 234-9.
49. Rao GP, Nadh BR, Hemaratnan A, et al; Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Report of four cases. J Neurosurg 1995; 83: 359-62.
50. Jha DK, Mishra V, Choudhary A, et al; Factors affecting the outcome of neuroendoscopy in patients with tuberculous meningitis hydrocephalus: a preliminary study. Surg Neurol 2007; 68: 35-41; discussion -2.
51. Rotbart HA; Viral meningitis. Semin Neurol 2000; 20: 277-92.
52. Kosters K, Nau R, Bossink A, et al; Rapid Diagnosis of CNS Tuberculosis by a T-Cell Interferon-gamma Release Assay on Cerebrospinal Fluid Mononuclear Cells. Infection 2008.